Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current therapy of prostate carcinoma]

O M Reich1, P Faul

  • 1Klinikum Memmingen, Urologische Klinik.

Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung
|August 14, 1998
PubMed
Summary

Prostate cancer (PCA) diagnosis is improving with prostate-specific antigen (PSA) tests. However, optimal treatment remains individualized, focusing on quality of life over survival for certain stages.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of the 2022 German trauma team activation criteria: a national registry study with focus on geriatric-specific modifiers.

Scandinavian journal of trauma, resuscitation and emergency medicine·2026
Same author

Molecular confirmation of primary monophasic synovial sarcoma of the mandible: diagnosis and management.

The British journal of oral & maxillofacial surgery·2022
Same author

Overall survival is improved in mucinous adenocarcinoma of the colon.

International journal of colorectal disease·2014
Same author

[The role of lubrication in transurethral electrical resection].

Der Urologe. Ausg. A·2007
Same author

[Activity of antiseptic catheter lubricants against methicillin-resistant Staphylococcus aureus (MRSA)].

Der Urologe. Ausg. A·2005
Same author

[Analgesic compress with Instillagel following circumcision. Observations].

Der Urologe. Ausg. A·2003

Area of Science:

  • Oncology
  • Urology

Context:

  • Prostatic carcinoma (PCA) presents diagnostic and therapeutic challenges despite extensive research.
  • Early detection of PCA is enhanced by prostate-specific antigen (PSA) testing and its advancements.

Purpose:

  • To review the current controversies in the diagnosis and treatment of prostatic carcinoma.
  • To highlight the role of PSA in early PCA detection.
  • To discuss evolving therapeutic strategies for organ-confined and progressive PCA.

Summary:

  • Prostate-specific antigen (PSA) and its subtests facilitate earlier diagnosis of prostate cancer.
  • There is a lack of rigid therapeutic guidelines for PCA, necessitating individualized treatment plans.
  • Novel therapeutic concepts for organ-confined and progressive disease prioritize quality of life improvements.

Impact:

  • Improved early detection rates for prostate cancer through PSA advancements.
  • Shift towards patient-centered, quality-of-life-focused treatment strategies for PCA.
  • Potential for better management of organ-confined and progressive prostate cancer stages.

Related Experiment Videos